Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
0.00Prev. Close
0.00Volume
NATotal traded value
NAUpper Circuit
NALower Circuit
NAFundamentals
| Market Cap | ₹13Cr |
| ROE | 51.39% |
| P/E Ratio(TTM) | -4.54 |
| EPS(TTM) | -7.67 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.02 |
| Book Value | -7.21 |
| Debt to Equity | -3.87 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Parmax Pharma
Parmax Pharma Limited is an Indian company that manufactures key ingredients like bulk drugs, drug intermediates, and specialty chemicals for the pharmaceutical industry. The company's core objective is to operate its business in a way that creates sustainable, long-term value for all its stakeholders, including customers and shareholders. As of March 2024, nearly 73.13% of the company's shares were held in a modern, electronic dematerialized format.;
| Parent Organisation | Parmax Pharma Limited |
| BSE Symbol | 540359 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 69.07 | ||
| Neuland Laboratories | NA (0.00%) | 104.99 | ||
| Jubilant Pharmova | NA (0.00%) | 38.42 | ||
| Acutaas Chemicals | NA (0.00%) | 64.65 |